NDRA
ENDRA Life Sciences Inc.Company with tickers: NDRA
CIK
1681682
CUSIP
29273B500
Shares Outstanding
1,848,464
Website
https://www.endrainc.com
Investor Relations
https://investors.endrainc.com/
13F Activity (30d)
1 filings
1 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2024-11-22 | — | |
| 10-K | 2025-03-31 | 2024-12-31 | |
| 8-K | 2025-03-31 | — | |
| 10-K/A | 2025-04-07 | 2024-12-31 | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-05-30 | 2025-05-27 | |
| 8-K | 2025-06-11 | — | |
| 8-K | 2025-07-09 | — | |
| 8-K | 2025-07-23 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K/A | 2025-10-15 | 2025-10-10 | |
| 8-K | 2025-10-15 | 2025-10-10 | |
| 8-K | 2025-10-23 | — | |
| DEF 14A | 2025-10-28 | 2024-12-31 | |
| 8-K | 2025-10-30 | 2025-10-29 | |
| 8-K | 2025-11-14 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-11-28 | — | |
| 8-K | 2025-12-15 | 2025-12-09 | |
| 8-K | 2026-03-25 | 2026-03-19 | |
| 8-K | 2026-03-31 | — | |
| 10-K | 2026-03-31 | 2025-12-31 | |
| 8-K | 2026-04-21 | 2026-04-20 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-05-28 | 2026-05-27 |
Showing 101–126 of 126 filings